Literature DB >> 20367488

Epidemiology of acute mountain sickness on Jade Mountain, Taiwan: an annual prospective observational study.

Shih-Hao Wang1, Yu-Cheng Chen, Wei-Fong Kao, Yu-Jr Lin, Jih-Chang Chen, Te-Fa Chiu, Tai-Yi Hsu, Hang-Cheng Chen, Shih-Wei Liu.   

Abstract

Acute mountain sickness (AMS) is a pathophysiological symptom complex that occurs in high altitude areas. The AMS prevalence is reportedly 28% on Jade Mountain, the highest mountain (3952 m) in Taiwan. We conducted this study owing to the lack of annual epidemiological data on AMS in Taiwan. Between April 2007 and March 2008, 1066 questionnaires were completed by trekkers visiting Paiyun Lodge on Jade Mountain. Information in the questionnaire included demographic data, mountaineering experience, AMS history, and trekking schedule. Weather data were obtained from the Central Weather Bureau of Taiwan. The Lake Louise AMS score was used to record symptoms and diagnose AMS. The chi-square test or the Student t test was used to evaluate associations between variables and AMS. In our study, the AMS prevalence was 36%. It increased significantly at different rates at different locations on the Jade Mountain trail and varied significantly in different months. Rainy weather tended to slightly increase the incidence of AMS. A lower incidence of AMS was correlated with hig-altitude trekking experience or preexposure (p < 0.05), whereas a higher incidence of AMS was correlated with a prior history of AMS (p < 0.05). The trekkers with AMS were significantly younger, ascended faster from their residence to the entrance or to Paiyun Lodge, and ascended slower from the entrance to the Paiyun Lodge (p < 0.05), but the differences lacked clinical significance. No differences in the incidence of AMS based on blood type, gender, or obesity were observed. The most common symptom among all trekkers was headache, followed by difficulty sleeping, fatigue or weakness, gastrointestinal (GI) symptoms, and dizziness or lightheadedness. In conclusion, the AMS prevalence on Jade Mountain was 36%, varied by month, and correlated with trekking experience, preexposure, and a prior history of AMS. The overall presentation of AMS was similar to that on other major world mountains.

Entities:  

Mesh:

Year:  2010        PMID: 20367488     DOI: 10.1089/ham.2009.1063

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  11 in total

1.  Statement on Older Travellers: Committee to Advise on Tropical Medicine and Travel.

Authors:  K L McClean
Journal:  Can Commun Dis Rep       Date:  2011-07-21

2.  Three-Minute Step Test for Predicting Acute Mountain Sickness: A Post Hoc Analysis of Rhodiola Crenulata Extract for Prevention of Acute Mountain Sickness, a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Authors:  Hsiang Yun Lo; Lisa Li-Chuan Chen; Deng-Huang Su; Chung-Hsien Chen; Tai-Yi Hsu; Shih-Hao Wang; Yi-Ming Weng; Cheng-Wei Chan; Shih-Hao Wu; Hang-Cheng Chen; Te-Fa Chiu
Journal:  J Acute Med       Date:  2018-03-01

3.  Effects of chronic intermittent hypobaric hypoxia on prostate-specific antigen (PSA) in Chilean miners.

Authors:  Diana Elizabeth Alcantara-Zapata; Shrikant I Bangdiwala; Daniel Jiménez; Manolis Kogevinas; Nella Marchetti; Carolina Nazzal
Journal:  Occup Environ Med       Date:  2021-05-11       Impact factor: 4.948

4.  The impact of physical fitness and body mass index in children on the development of acute mountain sickness: A prospective observational study.

Authors:  Shih-Hao Wu; Yin-Chou Lin; Yi-Ming Weng; Yu-Hui Chiu; Wen-Cheng Li; Shih-Hao Wang; Chang-Wei Chan; Te-Fa Chiu; Kuo-Feng Huang; Chung-Hsien Chen
Journal:  BMC Pediatr       Date:  2015-05-08       Impact factor: 2.125

5.  Rhodiola crenulata extract for prevention of acute mountain sickness: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Te-Fa Chiu; Lisa Li-Chuan Chen; Deng-Huang Su; Hsiang-Yun Lo; Chung-Hsien Chen; Shih-Hao Wang; Wei-Lung Chen
Journal:  BMC Complement Altern Med       Date:  2013-10-31       Impact factor: 3.659

6.  Incidence and severity of acute mountain sickness and associated symptoms in children trekking on Xue Mountain, Taiwan.

Authors:  Fei-Ying Cheng; Mei-Jy Jeng; Yin-Chou Lin; Shih-Hao Wang; Shih-Hao Wu; Wen-Cheng Li; Kuo-Feng Huang; Te-Fa Chiu
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

7.  Ginkgo biloba extract for prevention of acute mountain sickness: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Tou-Yuan Tsai; Shih-Hao Wang; Yi-Kung Lee; Yung-Cheng Su
Journal:  BMJ Open       Date:  2018-08-17       Impact factor: 2.692

Review 8.  Sex-based differences in the prevalence of acute mountain sickness: a meta-analysis.

Authors:  Yun-Peng Hou; Jia-Lin Wu; Chao Tan; Yu Chen; Rui Guo; Yong-Jun Luo
Journal:  Mil Med Res       Date:  2019-12-09

9.  Incidence and Determinants of Acute Mountain Sickness in Mount Kinabalu, Malaysia.

Authors:  Su Lan Yang; Nor At'fina Ibrahim; Grazele Jenarun; Houng Bang Liew
Journal:  High Alt Med Biol       Date:  2020-06-30       Impact factor: 1.981

10.  A prospective epidemiological study of acute mountain sickness in Nepalese pilgrims ascending to high altitude (4380 m).

Authors:  Martin J MacInnis; Eric A Carter; Michael G Freeman; Bidur Prasad Pandit; Ashmita Siwakoti; Ankita Subedi; Utsav Timalsina; Nadia Widmer; Ghan Bahadur Thapa; Michael S Koehle; Jim L Rupert
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.